Panobinostat (LBH589) is an HDAC (histone deactylase) inhibitor of research interest for multiple diseases such as multiple myeloma. Panobinostat was reported to inhibit several human multiple myeloma cell lines with and IC50 ≥ 20nM. Panobinostat was also reported to induce expression of DNA damage response genes and induce apoptosis in Ph- acute lymphoblastic leukemia cells. Panobinostat has potential applications in several different forms of cancer, in addition to spinal muscular atrophy and HIV therapy.
1. Catley, L., et al. 2006. Blood. 108: 3441-3449. PMID: 16728695
2. Fiskus, W., et al. 2006. Mol. Cancer Ther. 5: 3096-3104. PMID: 17172412
3. Scuto, A., et al. 2008. Blood. 111: 5093-5100. PMID: 18349321
4. Sasaki, D., et al. 2011. Haematologica. PMID: 21228036. PMID: 21228036
Vedi quanti altri hanno usato Panobinostat (CAS 404950-80-7). Clicca sulla voce per laccesso a PubMed .
PMID: # 30515817 Liao, W. et al. 2019. J. Cell. Physiol. 234: 12646-12662.
PMID: # 31054975 Ali, I.|Ruiz, DG.|Ni, Z.|Johnson, JR.|Zhang, H.|Li, PC.|Khalid, MM.|Conrad, RJ.|Guo, X.|Min, J.|Greenblatt, J.|Jacobson, M.|Krogan, NJ.|Ott, M.| et al. 2019. Mol. Cell. 74: 1164-1174.e4.
PMID: # 29778644 Hepp, MI. et al. 2018. Biochim. Biophys. Acta.
PMID: # 26379230 Franken, H. et al. 2015. Nat Protoc. 10: 1567-93.
PMID: # 32365976 Cancers (Basel). 12:
La Santa Cruz Biotechnology, Inc. è un leader mondiale nello sviluppo di prodotti per il mercato della ricerca biomedica. Chiamaci al numero gratuito 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. Tutti i diritti riservati. "Santa Cruz Biotechnology", ed il logo Santa Cruz Biotechnology, Inc."Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", il logo San Juan Ranch, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", ed "EZ Touch" sono marchi registrati dalla Santa Cruz Biotechnology, Inc.
Tutti i marchi sono proprietà dei rispettivi proprietari.